Sensitive detection of cereal fractions that are toxic to celiac disease patients by using monoclonal antibodies to a main immunogenic wheat peptide

American Journal of Clinical Nutrition

Volumn 87, Issue 2, 2008, Pages 405-414

  Morón, Belén ^a   Cebolla, Ángel ^b   Manyani, Hamid ^a   Álvarez Maqueda, Moisés ^b   Megías, Manuel ^a   Thomas, María Del Carmen ^c   López, Manuel Carlos ^c   Sousa, Carolina ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b Biomedal Ltd   (Spain)

^c INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

33 mer peptide; Celiac disease; Enzyme linked immunosorbent assays; Gluten; Monoclonal antibodies

Indexed keywords

ALPHA 2 GLIADIN; GLIADIN; GLUTEN; MONOCLONAL ANTIBODY; PEPTIDE; PROLAMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BARLEY; CELIAC DISEASE; CEREAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD ANALYSIS; GLUTEN FREE DIET; IMMUNOTOXICITY; MAIZE; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PROTEIN DEGRADATION; RICE; RYE; WESTERN BLOTTING; WHEAT;

AVENA; HORDEUM; SECALE CEREALE; TRITICUM AESTIVUM; ZEA MAYS;

EID: 38949114273     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/87.2.405     Document Type: Article

References (36)

1. Trier JS. Diagnosis of celiac sprue. Gastroenterology 1998;115:211-6.
2. Sollid LM. Celiac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2002;2:647-55.
3. Kagnoff MF. Celiac disease: pathogenesis of a model immunogenetic disease. J Clin Invest 2007;117:41-9.
4. Arentz-Hansen H, Fleckenstein B, Molberg Ø, et al. The molecular basis for oat intolerance in patients with celiac disease. PLoS Medic 2004;1:84-92.
5. Lee SK, Green PHR. Celiac sprue (the great modern-day imposter). Curr Opin Rheumatol 2006;18:101-7.
6. West J, Logan RFA, Card TR, Smith C, Hubbard R. Fracture risk in people with celiac disease: a population-based cohort study. Gastroenterology 2003;125:429-36.
7. Murray JA, Van Dyke C, Plevak MF, Dierkheising RA, Zinsmeister AR, Melton LJ. Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001. Clin Gastroenterol Hepatol 2003;1:19-27.
8. Shan L, Molberg Ø, Parrot I, et al. Structural basis for gluten intolerance in celiac sprue. Science 2002;297:2275-9.
9. Arentz-Hansen H, McAdam SN, Molberg Ø, et al. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology 2002;123:803-9.
10. Shan L, Qiao S-W, Arentz-Hansen H, et al. Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue. J Proteome Res 2005;4:1732-41.
11. Sorell L, López JA, Valdés I, et al. An innovative sandwich ELISA system based on an antibody cocktail for gluten analysis. FEBS Lett 1998;439:46-50.
12. Osman AA, Uhlig HH, Valdés I, Amin M, Méndez E, Mothes T. A monoclonal antibody that recognizes a potential celiac-toxic repetitive pentapeptide epitope in gliadins. Eur J Gastroenterol Hepatol 2001;13:1189-93.
13. Valdés I, García E, Llorente M, Méndez E. Innovative approach to low-level gluten determination in foods using a novel sandwich enzymelinked immunosorbent assay protocol. Eur J Gastroenterol Hepatol 2003;15:465-74.
14. Bermudo-Redondo MC, Griffin PB, Garzon-Ranzanz M, Ellis HJ, Ciclitira PJ, O'Sullivan CK. Monoclonal antibody-based assay for the sensitive detection of celiac disease toxic prolamins. Anal Chim Acta 2005;551:105-14.
15. Hill ID, Dirks MH, Liptak GS, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005;40:1-19.
16. Miller JH. Experiments in molecular genetics. New York, NY: Cold Spring Harbor Laboratory, 1972.
17. Cebolla A, Sousa C, de Lorenzo V. Rational design of a bacterial transcriptional cascade for amplifying gene expression capacity. Nucleic Acid Res 2001;29:759-66.
18. Cebolla A, Royo JL, de Lorenzo V, Santero E. Improvement of recombinant protein yield by a combination of transcriptional amplification and stabilization of gene expression. Appl Environ Microbiol 2002;68:5034-41.
19. Marañón C, Thomas MC, Puerta C, Alonso C, López MC. The stability and maturation of the H2A histone mRNAs from Trypanosoma cruzi are implicated in their post-transcriptional regulation. Biochim Biophys Acta 2000;1490:1-10.
20. Planelles L, Thomas MC, Pulgar M, Marañón C, Grabbe S, López MC. Trypanosoma cruzi heat-shock protein-70 kDa, alone or fused to the parasite KMP11 antigen, induces functional maturation of murine dendritic cells. Immunol Cell Biol 2002;80:241-7.
21. Udono H, Srivastava PK. Heat-shock protein-70 associated peptides elicit specific carrier immunity. J Exp Med 1993;178:1391-6.
22. Planelles L, Thomas MC, Alonso C, López MC. DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection. Infect Immun 2001;69:6558-63.
23. Ciupitu AMT, Petersson M, Kono K, Charo J, Kiessling R. Immunization with heat shock protein 70 from methylcholanthrene-induced sarcomas induces tumor protection correlating with in vitro T cell responses. Cancer Immunol Immunother 2002;51:163-70.
24. Howdle PD. Gliadin, glutenin or both? The search for the Holy Grail in celiac disease. Eur J Gastroenterol Hepatol 2006;18:703-6.
25. Wieser H. The precipitating factor in celiac disease. Baillieres Clin Gastroenterol 1995;9:191-207.
26. Kung PC, Chang TW, Zurawsky VR. Monoclonal antibodies in clinical investigations. Clin Biochem Contemp Theor Techniques 1984;3:89-115.
27. Lindquist S, Craig EA. The heat-shock proteins. Annu Rev Genet 1988;22:631-77.
28. Hartl FU. Molecular chaperones in cellular protein folding. Nature 1996;381:571-80.
29. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2002;2:185-94.
30. Morell M, Thomas MC, Caballero T, Alonso C, López MC. The genetic immunization with paraflagellar rod protein-2 fused to the HSP70 confers protection against late Trypanosoma cruzi infection. Vaccine 2006;24:7046-55.
31. Qazi KR, Oehlmann W, Singh M, López MC, Fernández C. Microbial heat shock protein 70 stimulatory properties have different TLR requirements. Vaccine 2007;25:1096-103.
32. Picarelli A, Di Tola M, Sabbatella L, et al. Immunologic evidence of no harmful effect of oats in celiac disease. Am J Clin Nutr 2001;74:137-40.
33. Thompson T. Gluten contamination of commercial oat products in the United States. N Engl J Med 2004;351:2021-2.
34. Lundin KEA. HLA-DQ8 as an Ir gene in celiac disease. Gut 2003;52:7-8.
35. Catassi C, Fabiani E, Iacono G, et al. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr 2007;85:160-6.
36. Bernardo D, Garrote JA, Fernández-Salazar L, Riestra S, Arranz E. Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides. Gut 2007;56:889-90.